Pradeep B Lukka

13PUBLICATIONS
80CO-AUTHORS
AllergyCancer therapy (excl. chemotherapy and radiation therapy)PharmacogenomicsInfant and child healthMajor global burdens of disease
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (13)

|May 27, 2026
Eosinophilic Depletion with Benralizumab, Mepolizumab, and Depemokimab: A Modeling Study.

|Jan 27, 2026
Phase I/II Study of the PARP Inhibitor Olaparib and Irinotecan in Children and Young Adults with Recurrent/Refractory Malignancies: Arm D of the AcSé-ESMART Trial.

Susanne A Gatz, Pablo Berlanga, Gwénaël Le Teuff

|Jun 23, 2025
Population Pharmacokinetics and Exposure-Response Analysis of Benralizumab in Chinese Adults, Adolescents, and Pediatric Participants with Severe Eosinophilic Asthma.

Yuwen Jin, Benjamin Guiastrennec, Miriam Stuke

|Mar 16, 2024
Benralizumab in children with severe eosinophilic asthma: Pharmacokinetics and long-term safety (TATE study).

H James Wedner, Takao Fujisawa, Theresa W Guilbert

|Feb 17, 2024
Benralizumab does not elicit therapeutic effect in patients with chronic spontaneous urticaria: results from the phase IIb multinational randomized double-blind placebo-controlled ARROYO trial.

Sabine Altrichter, Ana Maria Giménez-Arnau, Jonathan A Bernstein

|Jun 28, 2023
Development of a Minimalistic Physiologically Based Pharmacokinetic (mPBPK) Model for the Preclinical Development of Spectinamide Antibiotics.

Keyur R Parmar, Pradeep B Lukka, Santosh Wagh

Pageof 3

Frequent Collaborators

8 joint publications

Bernd Meibohm

3 joint publications

Wei Li

2 joint publications

Duane D Miller

2 joint publications

Gregory T Robertson